Literature DB >> 11122754

Development and assessment of antiatherosclerotic therapies beyond low-density lipoprotein cholesterol and blood pressure.

C M Ballantyne1.   

Abstract

Mesh：

Substances：

Year:  2000        PMID： 11122754     DOI： 10.1007/s11883-000-0059-3

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN： 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  13 in total

1.  Coronary calcium does not accurately predict near-term future coronary events in high-risk adults.

Authors:  R C Detrano; N D Wong; T M Doherty; R M Shavelle; W Tang; L E Ginzton; M J Budoff; K A Narahara
Journal:  Circulation       Date:  1999-05-25       Impact factor: 29.690

2.  Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

Authors:  S Yusuf; P Sleight; J Pogue; J Bosch; R Davies; G Dagenais
Journal:  N Engl J Med       Date:  2000-01-20       Impact factor: 91.245

3.  Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.

Authors:  H B Rubins; S J Robins; D Collins; C L Fye; J W Anderson; M B Elam; F H Faas; E Linares; E J Schaefer; G Schectman; T J Wilt; J Wittes
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

4.  The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

Authors: 
Journal:  Arch Intern Med       Date:  1997-11-24

5.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.

Authors:  S Hulley; D Grady; T Bush; C Furberg; D Herrington; B Riggs; E Vittinghoff
Journal:  JAMA       Date:  1998-08-19       Impact factor: 56.272

6.  Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects.

Authors:  Y Arad; L A Spadaro; K Goodman; A Lledo-Perez; S Sherman; G Lerner; A D Guerci
Journal:  Circulation       Date:  1996-06-01       Impact factor: 29.690

7.  Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. REGRESS Study Group.

Authors:  A J van Boven; J W Jukema; A H Zwinderman; H J Crijns; K I Lie; A V Bruschke
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

Review 8.  Mechanism of action of fibrates on lipid and lipoprotein metabolism.

Authors:  B Staels; J Dallongeville; J Auwerx; K Schoonjans; E Leitersdorf; J C Fruchart
Journal:  Circulation       Date:  1998-11-10       Impact factor: 29.690

Review 9.  Clinical trial endpoints: angiograms, events, and plaque instability.

Authors:  C M Ballantyne
Journal:  Am J Cardiol       Date:  1998-09-24       Impact factor: 2.778

Review 10.  Low-density lipoproteins and risk for coronary artery disease.

Authors:  C M Ballantyne
Journal:  Am J Cardiol       Date:  1998-11-05       Impact factor: 2.778
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.